In this paper, we conclude that the reduction of SIRT1 molecular activity, on the one hand, leads to cell cycle arrest through p53/CDK2 signaling, and on the other hand, induces inflammation through the activation of NF-κB signaling pathway, both of which jointly promote aging and eventually form AAA. Here, CDK2 is linked to triple-A syndrome.